C1514474||prognostic features
C0152035||Chinese
C1556094||Japanese
C0242379||lung cancer
C0035363||retrospectively
C1516221||prognosis
C0242379||lung cancer
C0019994||First Affiliated Hospital
C0019994||CMU1
C0019994||Shengjing Hospital
C0019994||CMUS
C0019994||Tumor Hospital
C0019994||CMUT
C0000872||China Medical University
C0019994||First Affiliated Hospital
C0017446||Dalian
C0019994||DMU
C0017446||Jinzhou
C0019994||JMU
C0000872||Medical University
C0019994||Takaoka Kouseiren Hospital
C0019994||Takaoka
C0022341||Japan
C1556094||Japanese
C0242379||lung cancer
C0475440||tumor size
C1515169||TNM staging
C0007137||squamous cell carcinoma
C0262584||small
C0206704||large cell carcinomas
C0152035||Chinese
C0038953||Survival analysis
C0475440||tumor size
C1514474||prognostic factor
C1556094||Japanese
C0152035||Chinese
C0006826||cancer
C0019994||DMU
C0019994||CMUS
C0001418||adenocarcinoma
C0019994||hospitals
C0019994||CMUT
C0019994||CMU1
C0007137||squamous cell carcinoma
C0019994||CMUT
C0019994||CMU1
C0019994||JMU
C0206704||large
C0262584||small cell carcinoma
C0019994||Takaoka
C0019994||CMU1
C1515169||TNM staging
C0019994||CMUT
C0019994||JMU
C0019994||Takaoka
C0242379||lung cancer
C0475440||tumor size
C0001418||adenocarcinoma
C1515169||TNM staging
C0242379||lung cancer
C0475440||tumor size
C0001418||adenocarcinoma
C1515169||TNM staging
C0001792||elder
C0019994||Takaoka
C2919552||survival time
C0152035||Chinese
C1556094||Japanese
C0242379||lung cancer
C0281206||prevention
C0242379||lung cancer
C0220908||screening strategy